Document:

<PAGE>

                                                                    Exhibit 10.2

Confidential Treatment. The portions of this exhibit that have been replaced
with "[*****]" have been filed separately with the Securities and Exchange
Commission and are the subject of an application for confidential treatment.

                            TISSUE RECOVERY AGREEMENT

      THIS TISSUE RECOVERY AGREEMENT (this "Agreement"), effective on this 15th
day of April, 1999, is by and between Regeneration Technologies, Inc., a Florida
corporation having its principal place of business at 1 Innovation Drive,
Alachua, Florida ("RTI"), and the University of Florida Tissue Bank, Inc., a
Florida not-for-profit corporation having its principal place of business at 2
Innovation Drive, Alachua, Florida ("UFTB").

                                   WITNESSETH

      WHEREAS, RTI and UFTB are parties to that certain agreement entitled, the
"Tissue Recovery, Processing and Distribution Agreement" made and entered into
by the parties on the 23rd of January, 1998, and the "Revised Agreement on
Intercompany Service Billing and Inventory Ownership" made and entered into the
11th of January, 1999 (the "Previous Agreements") attached hereto as Composite
Exhibit "A"; and

      WHEREAS, on the effective date of this Agreement the parties are also
entering into the "Programs Transfer Agreement"; and

      WHEREAS, the parties wish to replace the Previous Agreements with both
this Agreement and the Programs Transfer Agreement; and

      WHEREAS, the parties wish to have all other written agreements between the
parties remain in full force and effect; and

      WHEREAS, RTI recovers and processes human donor tissue and distributes the
resulting allograft tissue for implant surgeries throughout the world; and

      WHEREAS, RTI owns valuable proprietary and intellectual property rights
and substantial technical expertise which it uses to produce allograft tissue;
and

      WHEREAS, UFTB desires to recover and provide human tissue to RTI for
producing allograft tissue and for conducting research, and both parties desire
to cooperate to increase the amount of human tissue available for the production
and

[CONFIDENTIAL]
                                       1
<PAGE>

distribution of allograft tissue by RTI internationally, nationally, and in
UFTB's service area of Florida and Georgia.

      NOW, THEREFORE, in view of the representations made above and in
consideration of the terms and conditions set forth below, the parties agree as
follows:

                         ARTICLE I - General Obligations

      1.1 Upon the effective date of this Agreement and upon the simultaneous
execution of the Programs Transfer Agreements, the Previous Agreements shall
terminate.

      1.2 As consideration for RTI entering into this Agreement, for the term of
this Agreement UFTB shall:

            a. supply the "Exclusive Tissues" set forth on Exhibit "B" attached
hereto, solely to RTI;

            b. diligently endeavor to provide human donor tissues to RTI which
meet or exceed RTI's requirements for quality control, quality assurance, and
other specifications set forth in RTI's specifications schedule and standard
operating procedures (the SOPs) as are currently in effect; RTI may modify the
specifications schedule and SOPs only after ninety (90) days written notice to
UFTB;

            c. supply the "Non-Exclusive Tissue" set forth on Exhibit B to RTI
upon the following terms:.

                  (1) RTI shall have a right of first refusal on all
Non-Exclusive Tissue.

                  (2) UFTB shall make such Non-Exclusive Tissue available to RTI
under the best fee and payment terms that UFTB would offer to any third party.
UFTB shall provide such terms and conditions in writing to RTI upon request by
RTI. In the event that RTI requests any Non-Exclusive Tissue, RTI shall have
fifteen (15) days from its receipt of such written fee and payment terms from
UFTB to accept or reject such fee and payment terms.

                                       2
<PAGE>

                  (3) In the event that RTI rejects the offer of any tissue from
UFTB by giving notice of such rejection in writing to UFTB, UFTB shall have the
right to offer such tissue to a third party.

      1.3 On or about the effective date herein, UFTB shall provide RTI with a
copy of UFTB's Donor related recovery and screening forms and the parties will
work together to make form related changes as required by RTI.

      1.4 As consideration for UFTB entering into this Agreement with RTI, RTI
shall:

            a. diligently endeavor to provide allograft tissue to hospitals in
Florida and Georgia at levels of service and tissue safety, reasonably the same
as that provided by UFTB as of the date of this Agreement. Such services shall
include the hiring of sales/distribution staff and local distributors;

            b. not distribute or otherwise transfer any Exclusive Tissue
received from UFTB, to any third party whose sole purpose is to distribute such
transferred Exclusive Tissue or the allograft tissue resulting from such
transferred Exclusive Tissue, without UFTB's express prior written approval; and

            c. for the ten (10) year term of this Agreement, accept and make
payment for all Exclusive Tissue provided by UFTB, under the terms and
conditions set forth hereunder.

            d. For the ten (10) year term of this Agreement, as additional
consideration for UFTB's grant to RTI of a right of first refusal on all
Non-Exclusive Tissue, RTI agrees that any and all wholly-owned subsidiaries of
RTI, whether or not such subsidiary exists today or is to be formed or acquired
in the future, shall guarantee the payment obligations of RTI as set forth in
Article 1.4(c) herein, and RTI shall cause such subsidiaries to execute any and
all documents necessary to effect the intent of such agreement to guarantee such
payment obligation; provided however, such guarantee by such subsidiary shall
continue only during the time period that such subsidiary is wholly owned
directly or indirectly by RTI, and nothing in this Agreement shall require such
subsidiary to continue to provide such guarantee in the event that RTI no longer
owns a

                                       3
<PAGE>

majority of the stock in such subsidiary, or if such subsidiary is sold, or if
the shares in such subsidiary are sold to the public through a public offering.

      1.5 In the event that RTI desires to receive any tissues which are not an
Exclusive Tissue from UFTB, RTI shall use its best efforts to provide UFTB with
thirty (30) days advance notice of such tissue need. Absent other arrangements
made in advance by the parties, in the event that RTI desires to no longer
receive any tissue previously accepted by RTI (other than the Exclusive Tissue),
RTI shall provide UFTB with ninety (90) days advance written notice of RTI's
intention to no longer receive such tissue.

      1.6 RTI shall assume custodianship from UFTB of the "Consignment
Allograft" -- Exhibit 1.6 attached hereto, on a consignment basis. Within
fifteen (15) days from the end of any calendar month in which any Consignment
Allograft was distributed by RTI, RTI shall provide UFTB with a written
accounting of such distributed Consignment Allograft indicating the amount
invoiced to the customer for such distributed Consignment Allograft and the
calculation for amount due to UFTB, along with a check for such amount due.
The amount due UFTB by RTI shall be equal to the dollar amount invoiced to
the customer by RTI, for the Consignment Allograft itself, less a [*****]
commission to be retained by RTI. In the event that UFTB distributes any of
the Consignment Allograft, as a commission to RTI, UFTB shall remit to RTI
[*****] of the dollar amount UFTB has invoiced to any customer, for the
Consignment Allograft itself. UFTB shall provide RTI with a written
accounting of such distributed Consignment Allograft indicating the amount
invoiced to the customer for such distributed Consignment Allograft and the
calculation for amount due to RTI, along with a check for such amount due,
within fifteen (15) days from the end of any calendar month in which any
Consignment Allograft was distributed by UFTB.

      1.7 No later than ninety (90) days from the first anniversary of the
effective date of this Agreement, and every anniversary thereafter for the term
of this Agreement, the parties shall convene to discuss, in good faith,
adjustments to the "Reimbursement Schedule" set forth on Exhibit B.

[CONFIDENTIAL]
                                       4
<PAGE>

                ARTICLE II - Acceptance and Rejection of Tissues

      2.1 RTI shall accept tissue from UFTB if such tissues meet or exceed the
requirements set forth on the specifications schedule and the SOPs, and in the
event that any tissues provided or expected to be provided to RTI by UFTB do not
meet such requirements, as determined by RTI, UFTB shall have the right to make
such tissues available to any third party.

      2.2 Exclusive Tissues shall be regularly provided to RTI as recovered by
UFTB under this Agreement.

      2.3 Within thirty (30) days of RTI's rejection of any tissue supplied by
UFTB due to a failure to meet the requirements set forth on the specifications
schedule or the SOPs, RTI shall notify UFTB in writing of such rejection(s), and
state the reason(s) for such rejection(s). RTI shall be responsible for the
proper storage, tracking, handling, and disposition of any rejected tissues and
the associated costs of such activities thereof

                         ARTICLE III - Fees and Payments

      3.1 Payment by RTI to UFTB for amounts due under this Agreement for
recovery services shall be based upon the fees set forth in the Reimbursement
Schedule, and such payment shall be made in accordance with this Article 3.1.

            a. For the period from April 16, l999 through July 3l, 1999, an
accounting shall be provided to UFTB by RTI of all donors and donor tissue
received from UFTB during the semi-monthly periods ending on the 15th day and
the 1st day of each month. Such accounting shall list the recovery fee due to
UFTB for the donors received (in total, the "Donor Fees"), computed as if all
donors and donor tissue received from UFTB during the period had passed medical
release. The accounting shall also list each donor or donor tissue which, during
the same semi-monthly period, was medically rejected and, for each such
medically rejected donor, the computed difference between the recovery fee for
that donor as if medically accepted and the fee as medically rejected (in total,
the "Rejection Credits"). Within ten (10) business days of the end of each of

                                       5
<PAGE>

those semi-monthly periods, RTI shall pay UFTB the net amount of the Donor Fees
less the Rejection Credits.

            b. For the period from August 1, 1999 through October 31, 1999, an
accounting shall be provided to UFTB by RTI of all donors and donor tissue
received from UFTB during the monthly periods ending on the last day of each
month. Such accounting shall list the recovery fee due to UFTB for the donors
received (in total, the "Donor Fees"), computed as if all donors and donor
tissue received from UFTB during the period had passed medical release. The
accounting shall also list each donor or donor tissue which, during the same
monthly period, was medically rejected and, for each such medically rejected
donor, the computed difference between the recovery fee for that donor as if
medically accepted and the fee as medically rejected (in total, the "Rejection
Credits"). By the 20th day following each of the three (3) monthly periods, RTI
shall pay UFTB the net amount of the Donor Fees less the Rejection Credits.

            c. For each monthly period beginning November 1, 1999, an accounting
shall be provided to UFTB by RTI, by the l5th day of the following month, of all
donors and donor tissue received from UFTB during the preceding month, and of
all donors and donor tissue passing medical release during that preceding month.
Such accounting shall list the recovery fee due to UFTB for the donors medically
released during the month (in total, the "Donor Fees"). Such accounting shall
also list each donor or donor tissue which, during the monthly period, was
medically rejected and which had been received by RTI prior to November 1, 1999,
and for which RTI had already reimbursed a full recovery fee as if medically
released. For each of these pre-November 1 donors which were subsequently
medically rejected, the accounting shall list the computed difference between
the recovery fee for that donor as if medically accepted and the fee as
medically rejected (in total, the "Rejection Credits"). Within thirty (30) days
of the end of each monthly period, RTI shall pay UFTB the net amount of the
Donor Fees less the Rejection Credits.

            d. UFTB shall be responsible for and shall pay all shipping casts
associated with providing donors or donor tissue to RTI under this Agreement.

                                       6
<PAGE>

            e. UFTB shall provide all documentation to RTI necessary to perform
the master donor chart review, medical director sign-off. Both RTI and UFTB
shall use their best efforts to obtain medical releases promptly.

            f. Payments due to either party under this Article III which are
more than thirty (30) days past due shall bear interest at a rate equal to RTI's
then current commercial lending rate.

      3.2. RTI shall pay a royalty to UFTB, for UFTB's remission to the
University of Florida Department of Orthopedics (UFDO), pursuant to the
agreement entitled, "Agreement Between University of Florida and University of
Florida Orthopedic Tissue Bank, Inc.", made effective by and between UFTB and
UFDO on the 22nd day of October 1996. RTI shall calculate such royalty payment
to UFTB by multiplying the "Royalty Rate" by the "Qualifying Revenue". The
Royalty Rate is derived from Table 3.2 below and the Qualifying Revenue is
defined as "A" divided by "B" multiplied by "C" where:

            a. "A" equals the number of donors received by RTI from the
"Existing Agencies" - Exhibit 3.2(a)-1 attached hereto, which RTI utilizes to
produce the "Conventional Allograft" - Exhibit 3.2(a)-2 attached hereto;

            b. "B" equals the number of all donors utilized by RTI to produce
Conventional Allograft;

            c. "C" equals the revenue (net of returns, allowances, discounts,
shipping costs, and sales taxes) resulting from RTI's distribution of
Conventional Allograft derived from all RTI donors; and

            d. the number of donors and the revenue amount used to calculate A,
B, and C are derived from the calendar month for which such royalty is due.

            e. RTI shall keep for at least two years after the expiration or
termination of this Agreement full and accurate books of accounts and records
covering all distribution of the Conventional Allograft and the calculation of
royalties paid to UFTB. RTI also shall permit UFTB or its authorized
representative, upon reasonable notice during regular business hours, to conduct
reasonable audits of RTI's books, records and inventories to verify the accuracy
of royalties paid under this Article 3.2. If any such

                                       7
<PAGE>

audit of RTI's books and records indicates a royalty underpayment to UFTB of at
least five percent (5%) and $5,000, when compared to payments made and reports
previously furnished to UFTB for the respective time period, RTI shall bear
UFTB's direct cost of such audit. RTI shall pay UFTB any such unpaid amounts due
UFTB, as disclosed by the audit, plus interest (at RTI's current commercial
lending rate) and, if applicable, such direct audit costs, within ten (10) days
of UFTB's written demand.

                                    Table 3.2

          Annual Qualifying Revenue Range*        Royalty Rate
          Up to $5,000,000                           [*****]
          $5,000,001-$6,000,000                      [*****]
          $6,000,001-$7,000,000                      [*****]
          $7,000,001 -$9,000,000                     [*****]
          Over $9,000,000                            [*****]

          * Each annual period being July 1 to June 30

            e. No later than fifteen (15) business days from the end of each
calendar month for the term of this Agreement, RTI shall provide UFTB with an
accounting of such royalties including a breakdown of Qualifying Revenue by each
Existing Agency for such month along with a check for the appropriate dollar
amount made payable to UFTB, or upon written request from UFTB, RTI will remit
such royalty check and a copy of the accounting directly to the UFDO.

               ARTICLE IV - Technical and Professional Assistance

      4.1 The parties acknowledge that they each have certain technical
knowledge and expertise and each party agrees to offer the other party
reasonable technical and professional assistance which may be needed from time
to time to enhance the quality and increase the quantity of tissues made
available to RTI.

[CONFIDENTIAL]
                                       8
<PAGE>

      4.2 UFTB offers its staff for projects as requested by RTI on a
case-by-case basis, based on the hourly rate of the gross salary and benefits,
plus thirty (30%) percent, of the specific UFTB employee's wage assigned to the
project, plus reasonable non-salaried expenses.

      4.3 In the event that an RTI "trainee" accompanies a UFTB employee, or
other UFTB appointed person, on an Exclusive Tissue recovery for the purpose of
Exclusive Tissue recovery training, RTI shall pay UFTB a fee of Two Hundred
Fifty Dollars ($250) for each such recovery training occurrence within thirty
(30) days of receipt of invoice from UFTB.

                        ARTICLE V - Term and Termination

      5.1 The term of this Agreement shall be for a period of ten (10) years
commencing with the effective date set forth above.

      5.2 This Agreement may be terminated early:

            a. by either party due to a material breach by the other party of
any of its obligations or covenants herein, if the breaching party fails to
remedy said breach within thirty (30) calendar days of receiving written notice
from the non-breaching party of such breach; or

            b. by either party upon an adjudication of the other party as
bankrupt or insolvent, or the admission in writing by such party of its
inability to pay its debts as they mature; or an assignment by such other party
for the benefit of its creditors; or such other party applying for or consenting
to the appointment of a receiver, trustee or similar officer for its assets; or
the appointment of such receiver, trustee or similar officer for such other
party's assets without the application or consent of such party, if such
appointment shall continue undischarged for a period of ninety (90) days.

                                       9
<PAGE>

            ARTICLE VI- Warranty. Indemnity and Other Representations

      6.1 Both parties represent and warrant that the rights granted herein do
not violate any rights previously granted by either party to any third party.

      6.2 RTI warrants that:

            a. it is a corporation duly organized, validly existing and in good
standing under the laws of Florida and has all corporate power and authority to
execute and deliver this Agreement and to perform its obligations hereunder;

            b. the execution, delivery and performance by RTI of this Agreement
and the consummation of the transactions contemplated hereby has been duly and
validly authorized by all requisite corporate action, and no other corporate act
or proceeding on the part of RTI is necessary to authorize the execution and
delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby;

            c. it is not subject to nor obligated under its Articles of
Incorporation or bylaws, any applicable law, rule or regulation of any
governmental authority , or any agreement, instrument, license or permit or
subject to any order, writ, injunction or degree, which would be breached or
violated by its execution, delivery or performance of this agreement;

            d. its execution and delivery of this Agreement and the performance
of its obligations hereunder, including the obligations of any payments
hereunder, do not and will not conflict with, violate, or result in any default
under any agreement, instrument or other contract to which RTI is a party or by
which it is bound; and

            e. there are no claims, actions, suits or other proceedings pending,
or to the knowledge of RTI threatened which, if adversely determined, would
adversely affect the ability of RTI to consummate the transactions contemplated
by this Agreement or perform its obligations hereunder.

      6.3 UFTB warrants that:

            a. it is a corporation duly organized, validly existing and in good
standing under the laws of Florida and has all corporate power and authority to
execute and deliver this Agreement and to perform its obligations hereunder;

                                       10
<PAGE>

            b. the execution, delivery and performance by UFTB of this Agreement
and the consummation of the transactions contemplated hereby has been duly and
validly authorized by all requisite corporate action, and no other corporate act
or proceeding on the part of UFTB is necessary to authorize the execution and
delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby;

            c. it is not subject to nor obligated under its Articles of
Incorporation or bylaws, any applicable law, rule or regulation of any
governmental authority, or any agreement, instrument, license or permit or
subject to any order, writ, injunction or degree, which would be breached or
violated by its execution, delivery or performance of this agreement;

            d. its execution and delivery of this Agreement and the performance
of its obligations hereunder, including the obligations of any payments
hereunder, do not and will not conflict with, violate, or result in any default
under any agreement, instrument or other contract to which UFTB is a party or by
which it is bound; and

            e. there are no claims, actions, suits or other proceedings pending,
or to the knowledge of UFTB threatened which, if adversely determined, would
adversely affect the ability of UFTB to consummate the transactions contemplated
by this Agreement or perform its obligations hereunder.

      6.4 Apart from any warranty expressly made in this Agreement, neither
party hereto makes any representations and extends no warranties of any kind,
either express or implied. Nothing in this Agreement shall be construed as an
obligation to furnish any other information, except as specifically provided
herein, or a warranty or representation by RTI that it will not procure any
tissues from other sources.

      6.5 UFTB warrants to RTI that all tissues are screened according to local,
state, federal regulations in force at the time of recovery.

      6.6 UFTB shall at all times during the term of this Agreement and
thereafter, indemnify, defend and hold RTI, RTI Affiliates (as hereinafter
defined), or any of its assigns, harmless against all claims and expenses,
including legal expenses and reasonable attorney fees, arising out of any other
claims, proceeding, demand, expense,

                                       11
<PAGE>

loss, and liability of any kind whatsoever including any breach of its
obligations hereunder (collectively, "RTI Losses") resulting from the activities
of UFTB under this Agreement, except where such RTI Losses result solely from
RTI's negligence or willful misconduct. As used in this Agreement, "RTI
Affiliates" shall mean RTI's directors, officers, agents and employees.
Notwithstanding the above, RTI, at all times, reserves the right to retain
counsel of its own, at its own expense, to defend RTI's interests. This Article
6.6 shall survive the termination of this Agreement.

      6.7 RTI shall at all times during the term of this Agreement and
thereafter, indemnify, defend and hold UFTB, UFTB Affiliates (as hereinafter
defined), or any of its assigns, harmless against all claims and expenses,
including legal expenses and reasonable attorney fees, arising out of any other
claims, proceeding, demand, expense, loss, and liability of any kind whatsoever
including any breach of its obligations hereunder (collectively, "UFTB Losses")
resulting from the activities of RTI under this Agreement, except where such
UFTB Losses result from solely UFTB's negligence or willful misconduct. As used
in this Agreement, "UFTB Affiliates" shall mean UFTB's directors, officers,
agents and employees. Notwithstanding the above, UFTB at all times reserves the
right to retain counsel of its own, at its own expense, to defend UFTB's
interests. This Article 6.7 shall survive the termination of this Agreement.

      6.8 Each party warrants that it now maintains and will continue to
maintain liability insurance coverage in an amount of two million dollars
($2,000,000) for UFTB, and five million dollars ($5,000,000) for RTI, per
occurrence and that such insurance coverage lists the other party as an
additional insured. Each party shall provide the other party with at least
thirty (30) days written notice of any change or cancellation of such insurance
coverage.

                             ARTICLE VII- Assignment

      7.1 This Agreement has been entered into by RTI and UFTB in reliance upon
the particular qualifications of each party and is personal to each party.

                                       12
<PAGE>

            a. Neither this Agreement, nor any rights or obligations hereunder,
may be assigned, pledged or encumbered by UFTB or RTI without the express prior
written approval of the other party; provided however, RTI may assign this
Agreement, upon the prior written consent of UFTB, to a third party provided
that (i) such third party provides reasonably satisfactory evidence that the
third party is of equal or better financial condition than RTI and (ii) such
third party agrees to provide such assurances and agrees to execute such
agreements to meet the obligations of RTI under this Agreement. UFTB shall not
unreasonably withhold its consent to any such assignment.

            b. In the event that RTI desires to assign this Agreement, UFTB
shall provide RTI with written notice of its intention to accept or reject such
assignment within fifteen (15) business days of UFTB's receipt from RTI of such
submitted evidence regarding the third party. In the event that RTI does not
receive such written notice of intention from UFTB within such fifteen (15) day
time period, UFTB shall be deemed to have consented to such assignment. In the
event that UFTB withholds consent to such assignment, UFTB shall within such
fifteen (15) day time period, provide RTI, in writing, with the reasonable
reasons for withholding of such consent.

            c. For purposes of this Agreement any change in control of RTI shall
be deemed an assignment of this contract by RTI. Change in control shall mean
the change in ownership of a majority of the outstanding shares of common stock.

                          ARTICLE VIII - Miscellaneous

      8.1 A waiver of any specific breach of any provision of this Agreement
shall not be construed as a continuing waiver of other breaches of the same or
other provisions of this Agreement.

      8.2 The right of either party to terminate under the provisions of this
Agreement shall not be an exclusive remedy, and either party shall be entitled,
if the circumstances warrant, alternatively or cumulatively, to damages for
breach of this Agreement, to an order requiring performance of the obligations
of this Agreement.

                                       13
<PAGE>

      8.3 Nothing herein shall be deemed to create an agency, joint venture or
partnership relationship between the parties hereto.

      8.4 This Agreement constitutes the entire agreement and understanding of
the parties with regard to the subject matter hereof, and supercedes the
Previous Agreements and all prior discussions, negotiations, understandings and
agreements between the parties concerning the subject matter hereof. Neither
party shall be bound by any definition, condition, warranty, right, duty or
covenant other than as expressly stated in this Agreement or as subsequently set
forth in a written document signed by both parties. Each party expressly waives
any implied right or obligation regarding the subject matter hereof. All other
written agreements between the parties shall remain in full force and effect.

      8.5 This Agreement shall be interpreted and construed in accordance with
the laws of the State of Florida and the parties agree that: (a) they are
subject to the jurisdiction of the state and Federal courts located within the
state of Florida; (b) the exclusive venue for actions related to this Agreement
shall be the Circuit Court for Alachua County, Florida or the United States
District Court having jurisdiction over Alachua County, Florida; and (c) in any
action brought to enforce or interpret the rights or obligations relating to
this Agreement, the prevailing party in such action shall be entitled to an
award of it's reasonable attorneys' fees and costs, including pre-suit and
appellate attorneys' fees and costs, from the non-prevailing party.

      8.6 This Agreement may be amended only by a written document signed by
authorized representatives of both parties.

      8.7 Each party hereto agrees to execute, acknowledge and deliver all such
further instruments as may be necessary or appropriate to carry out the intent
and purposes of this Agreement. This Agreement shall be binding upon and inure
to the benefit of the respective parties hereto, their heirs, legal
representatives, successors and permitted assigns.

      8.8 The headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this
Agreement.

                                       14
<PAGE>

      8.9 Should any part or provision of this Agreement be held unenforceable
or in conflict with the law of any jurisdiction, the validity of the remaining
parts or provisions shall not be affected by such holding. In the event a part
or provision of this Agreement is held unenforceable or in conflict with the law
affecting consideration to either party, the parties agree to negotiate in good
faith amendment of such part or provision in a manner consistent with the
intention of the parties as expressed in this Agreement.

      8.10 Neither party shall be responsible or liable to the other party for
nonperformance or delay in performance of any terms or conditions of this
Agreement due to acts or occurrences beyond the control of the non-performing or
delayed party including, but not limited to, acts of God, acts of government,
year 2000 related occurrences, wars, riots, strikes or other labor disputes,
shortages of labor or materials, fires and floods, provided the non-performing
or delayed party provides to the other party written notice of the existence and
the reason for such nonperformance or delay. The nonperformance or delay by
either party in excess of one hundred eighty (180) days shall constitute cause
for termination of this Agreement with such notice given in writing by one party
to the other.

      8.11 Any and all notices or other communications required or permitted by
this Agreement or by law to be served on or given to either party by the other
party shall be in writing and delivered or sent to:

      RTI:                     Jamie M. Grooms, Chief Executive Officer
                               Regeneration Technologies, Inc.
                               1 Innovation Drive
                               Alachua, FL 32615

      UFTB:                    Nancy R. Holland, Chief Executive Officer
                               University of Florida Tissue Bank, Inc.
                               1 Innovation Drive
                               Alachua, FL 32615
                               With copy to: Susan Collingwood
                               Office of General Counsel
                               University of Florida

                                       15
<PAGE>

      8.12 Each party may change its address for purposes of this Agreement
written notice to the other party. All notices or other communications shall
be deemed duly served and given on the date when personally delivered to the
party to whom it is directed, when sent by FedEx or other reasonably similar
courier, or when deposited in the United States mail, first class, postage
prepaid, and addressed to the party at the address in Article 8.11 herein.

       8.13 Absent express, prior written permission by the disclosing party
to the receiving party, the parties to this Agreement, their officers,
directors, employees and agents, shall strictly maintain the confidentiality
of, and shall not disclose to any third party, the personal data of donors,
any processes, patent applications, technical, financial and business
information, general or otherwise, and any other information normally treated
as confidential by the disclosing party. The parties to this Agreement shall
use their best efforts to assure that all of their employees and agents
maintain such confidentiality. This Article 8.13 shall survive the
termination of this Agreement.

      8.14 This Agreement shall be executed by each party in duplicate
originals, each of which shall be deemed an original, but both originals
together shall constitute only one and the same instrument.

                       (Signatures on the following page)

                                       16
<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate
on the signature page hereof.

Regeneration Technologies, Inc.

By: /s/ James M. Grooms
   --------------------------------
Title: President & CEO
      -----------------------------
Date: 7/16/99
     ------------------------------

University of Florida Tissue Bank, Inc.

By: /s/ Nancy Holland
   --------------------------------
Title: President and CEO
      -----------------------------
Date: 7/13/99
     ------------------------------

Attachments:

o     Composite Exhibit A

o     "Exclusive Tissue", "Non-Exclusive Tissues", "Reimbursement Schedule"
       --Exhibit B

o     "Consignment Allograft" -- Exhibit 1.6

o     "Existing Agencies"-- Exhibit 3.2(a)-1

o     "Conventional Allograft"-- Exhibit 3.2(a)-2

                                       17
<PAGE>

                      "Existing Agencies"- Exhibit 3.2(a)-1

[*****]
[*****]
[*****]
[*****]
[*****]
[*****]
[*****]
[*****]
[*****]
[*****]

[CONFIDENTIAL]<PAGE>

                                                                    EXHIBIT 10.3

Confidential Treatment. The portions of this exhibit that have been replaced
with "[*****]" have been filed separately with the Securities and Exchange
Commission and are the subject of an application for confidential treatment.

                  EXCLUSIVE DISTRIBUTORSHIP AGREEMENT

      This Exclusive Distributorship Agreement ("Agreement"), made and effective
this 6th day of June, 1998, by and between Regeneration Technologies, Inc., One
Innovation Drive, Alachua, Florida ("RTI") and Bard Urological Division, C.R.
Bard, Inc., 8195 Industrial Boulevard, Covington, Georgia ("Distributor").

      WHEREAS, RTI performs human tissue processing and distributes human
allograft tissue for use by physicians in implant procedures around the world;
and

      WHEREAS, RTI processes and distributes a certain human allograft tissue
termed Fascia Lata; and

      WHEREAS, Distributor is a manufacturer and distributor of medical devices
for use by physicians in the human genitourinary system; and

      WHEREAS, RTI desires to appoint Distributor, and Distributor desires to
accept appointment, as an exclusive distributor of certain Fascia Lata products
within a defined area as set forth herein.

      NOW, THEREFORE, in consideration of the premises and the mutual covenants
contained herein, the receipt and sufficiency of which is hereby acknowledged,
the parties agree as follows:

1.    Rights Granted. RTI hereby grants to Distributor the exclusive right, on
      the terms and conditions contained herein, to distribute "RTI Products"
      (as set forth below), and offer training and education related to such RTI
      Products, throughout the world (the "Territory"). The rights granted
      hereunder are limited to the following field of use (the "Field of Use"):
      Treatment of Voiding Dysfunctions or Pelvic Tissue Defects in the Human
      Genitourinary System.

      The exclusive right granted hereunder is contingent upon Distributor
      meeting the distribution quotas set forth in the "Distribution Quota
      Schedule" attached hereto. Nothing herein shall prevent or prohibit RTI
      from distributing any RTI Products to any customers outside the Field of
      Use.

2.    RTI Products. As used in this Agreement, the term "RTI Products" shall
      mean the products processed or distributed by RTI as follows: Fascia Lata
      (human allograft tissue with the specifications set forth in the "Fascia
      Lata Specifications" attached hereto).

3.    Terms of Distribution.

      A.    All distributions of RTI Products to Distributor's customers shall
            be made

[CONFIDENTIAL]
                                        1

<PAGE>

            pursuant to this Agreement and except as otherwise expressly agreed
            by RTI in advance, this Agreement shall control all aspects of the
            dealings between RTI and Distributor with respect to the RTI
            Products, and any additional or different terms in any Distributor
            order are hereby rejected.

      B.    RTI shall ship all RTI products directly to Distributor's customers
            as instructed by Distributor and RTI shall promptly invoice
            Distributor for: (1) the greater of forty percent (40%) of the Net
            Invoice Amount of all such shipments or the amount set forth in the
            Facsia Lata Fee Schedule; and (2) the respective freight charges for
            each such shipment to Distributor's customers. "Net Invoice Amount"
            as used in this Section 3(B) shall mean the total amount of RTI
            Product fees billed to such customers per shipment, net of freight,
            and returns approved by RTI. All orders are subject to acceptance by
            RTI and RTI shall diligently endeavor to fill all Distributor orders
            within the limitations set forth in Section 6 (A) herein.

      C.    Unless otherwise mutually approved in writing by the parties, the
            Fascia Lata Fee Schedule may be changed no more than once per twelve
            month period and such percentage of change shall not exceed the
            "Consumer Price Index" for the period since the last price change.
            RTI agrees to properly pack all items for shipment. Risk of loss due
            to damage or destruction of RTI Products shall be borne by
            Distributor's customer. The shipper will be selected by RTI unless
            Distributor requests a reasonable alternative. RTI covenants that
            the fees shall at all times be less than or equal to the fees
            charged by RTI to any third party for products supplied directly or
            indirectly by RTI which have or may have utility in the Field of Use
            ("MFN Fees") and that, if the MFN Fees are charged, then this
            Agreement shall be deemed automatically amended, without any further
            action of the parties, to provide that the fees billed to all of the
            Distributor's customers, for the period in which such third party is
            charged the MFN Fees, shall be equal to the MFN Fees; provided,
            however, that the MFN Fees may be increased in accordance with the
            terms of this Section 9(C), but only if the resultant increased fees
            are less than or equal to the MFN Fees."

      D.    RTI shall notify Distributor within three (3) days of RTI's receipt
            of: (i) any complaint from Distributor's customers which are related
            to RTI Products; or (ii) the return of any RTI Product and its
            proper documentation as set forth in the "Return Instructions"
            attached hereto. The intention of such provision as set forth in
            Section 3(D) herein is to allow Distributor, at its option, to
            respond directly to such customer.

4.    Payment. RTI shall invoice Distributor for all RTI Products shipped in the
      current month promptly after the close of that month's business. Included
      with such invoice will be a statement itemizing the shipments as to
      product type and quantities shipped by customer. Distributor shall pay all
      such invoices within thirty (30) days from receipt of invoice. RTI may
      impose a late payment charge of one percent (1%) per month on overdue
      amounts. Failure to pay such overdue amounts within thirty (30) days
      written notice from

                                         2

<PAGE>

      RTI shall, at RTI's option, be considered a material breach of this
      Agreement and RTI may suspend deliveries of RTI Products or seek other
      remedies available to it at law or equity.

5.    Supporting Policies. Distributor shall diligently endeavor to train and
      educate its customers about the RTI Products through all channels of
      distribution prevailing in the Territory, in conformity with RTI's
      established training and education policies and programs. Distributor will
      use commercially reasonable efforts to procure orders for RTI Products
      from responsible customers whom Distributor reasonably believes are
      capable of properly utilizing such RTI Products.

6.    RTI's General Duties.

      A.    RTI shall use its best efforts to supply the quantities of RTI
            Products as set forth on the "Distribution Quota Schedule" attached
            hereto.

      B.    RTI shall cause all RTI Products provided to Distributor's customers
            hereunder to be irradiated within the 1.5 to 2.5 MRAD range.

      C.    RTI shall adhere to all state, federal and country specific laws and
            regulations and RTI specifications pertaining to the donor recovery
            and processing for RTI Products.

7.    Distributor's General Duties.

      A.    Distributor's personnel and representatives shall be adequately
            trained by Distributor regarding the RTI Products. Distributor shall
            use commercially reasonable efforts to employ sufficient numbers of
            such personnel and representatives to properly train and educate
            Distributor's customers concerning the RTI Products in the
            Territory.

      B.    Within thirty (30) days of the effective date of this Agreement,
            Distributor shall provide RTI with a written, non-binding, annual
            distribution forecast, broken down by quarter. Ensuing quarterly
            distribution forecasts shall be provided every ninety (90) days
            thereafter, for the term of this Agreement, it being the intent of
            the parties to have at all times distribution forecasts for the
            current quarter and three following quarters. Distributor may amend
            its distribution forecasts provided such amendment is submitted to
            RTI, in writing, at least one quarter m advance.

8.    Distributor's Exclusivity. Distributor's exclusive rights hereunder are
      contingent upon Distributor's achieving the level of distribution set
      forth on the Distribution Quota Schedule provided, however, that RTI has
      supplied sufficient quantities of RTI Products as set forth on the
      Distribution Quota Schedule. Otherwise, in the event Distributor fails to
      fulfill the distribution requirements set forth on the Distribution Quota
      Schedule, RTI

                                         3

<PAGE>

      shall notify Distributor in writing of such failure within forty five (45)
      days after the end of the applicable Distribution Quota period.
      Distributor shall then have forty five (45) days within receipt of such
      notice to rectify the shortfall by paying RTI the respective shortfall
      amount or otherwise issuing a purchase order for RTI Products in the
      amount of such shortfall. In the event that distributor fails to pay such
      shortfall or issue such purchase order, RTI's sole and exclusive remedy
      shall be to promptly render this Agreement non-exclusive or terminate it
      in accordance with Section 17(i) herein. The delivery date(s) of any such
      purchase order as set forth in this Section 8 shall be mutually agreed
      upon in good faith between Distributor and RTI. Any make-up of the
      shortfall amount shall not be applicable to any other period's
      distribution quotas.

9.    Training and Education Policies. RTI will cooperate with Distributor in
      providing for effective training and education of RTI Products throughout
      the Territory and RTI's participation in such training and education shall
      be on a schedule mutually agreed to by the parties hereto. Distributor
      shall promptly compensate RTI for all travel related expenses for RTI
      employees, officers, or agents who participate in such training and
      education. All training, education, and related materials shall be at
      Distributor's expense; however, plans for such training and education and
      related materials shall first be submitted to RTI for its approval.

10.   Product Warranty Policies. In the event that any RTI Products are proven,
      to RTI's satisfaction, to have been defective at the time of distribution,
      RTI will make an appropriate adjustment in the original distribution fee
      charged for such product or, at RTI's election, replace the defective
      product.

11.   Indemnification.

      A.    RTI warrants that all RTI Products supplied to Distributor's
            customers hereunder shall be recovered from donors and processed in
            accordance with all state, federal and country specific laws and
            regulations and RTI specifications. RTI agrees to indemnify
            Distributor and hold Distributor harmless from any loss or claim
            arising out of defects in any of RTI Products existing at the time
            such Product is distributed by RTI to Distributor's customer(s),
            provided that Distributor gives RTI immediate notice of any such
            loss or claim and cooperates fully with RTI in the handling thereof.

      B.    Distributor and RTI each agree to indemnify and hold the other
            harmless from any loss or claim arising out of its negligence, the
            negligence of its agents, employees or representatives, in the
            processing, distribution, representation, warranty, use or other
            disposition of RTI Products and from breach of any purchase order
            arising hereunder or any obligation, representation, warranty and
            covenant herein.

      C.    Each party hereby covenants to maintain, for the term herein, a
            comprehensive general liability insurance policy in a minimum amount
            of three million dollars ($3,000,000) per occurrence and in the
            aggregate. Each party shall provide not

                                         4
<PAGE>

            less than thirty (30) days prior written notice to the other in the
            event of a change in coverage or policy cancellation. Upon the
            request of either party, the other party shall deliver to the
            requesting party a certificate evidencing such coverage.

12.   Order Processing and Rejection of RTI Products.

      A.    RTI will employ its best efforts to fill Distributor's orders
            promptly on acceptance, subject to availability of RTI Products.

      B.    Subject to the Return Instructions, Distributor or Distributor's
            customers shall notify RTI in writing if such customer chooses to
            reject all or any part of such shipment of RTI Product or, falling
            such notification, unless such RTI Product has a latent defect, the
            customer shall be deemed to have accepted such shipment for all
            purposes. With respect to latent defects, Distributor or
            Distributor's customers shall promptly notify RTI after such
            customer's discovery thereof, and such customer shall have the right
            to reject such RTI Product.

13.   Use of RTI Name. Distributor will not use, authorize or permit the use of,
      the name "Regeneration Technologies, Inc.," "RTI" or any other trademark
      or trade name owned by RTI or its corporate or business name in any way
      without the prior written approval of RTI. Distributor shall not contest
      the right of RTI to exclusive use of any trademark or trade name used or
      claimed by RTI.

15.   Use of University of Florida Name. The tradename "University of Florida
      Tissue Bank, Inc." shall be included on the packaging of all RTI Products.
      Distributor shall not use the name University of Florida or the University
      of Florida Tissue Bank, in any way or form, on any promotion for the
      distribution of Tissue, advertising, or any other form of publicity,
      without the prior written consent of RTI.

16.   Relationship of the Parties. The relationship between RTI and Distributor
      is that of vendor and vendee. Distributor, its agents and employees shall,
      under no circumstances, be deemed employees, agents or representatives of
      RTI. Distributor will not modify any of RTI Products without written
      permission from RTI. Neither Distributor nor RTI shall have any right to
      enter into any contract or commitment in the name of, or on behalf of the
      other, or to bind the other in any respect whatsoever.

17.   Term and Termination. This term of this Agreement shall be for a period
      often ten (10) years commencing with the effective date herein and upon
      the end of such term the Agreement shall continue until terminated by
      either party with at least thirty (30) days prior written notice to the
      other party. This Agreement may be terminated early:

      (i)   by either party due to a material breach by the other party of any
            of its obligations or covenants herein upon sixty (60) calendar days
            written notice to the breaching party, but only if such breaching
            party fails to remedy said breach within sixty (60) calendar days of
            such written notice;

                                         5
<PAGE>

      (ii)  by either party promptly upon the insolvency or filing for
            receivership or bankruptcy by the other party.

18.   Obligations on Termination. On termination of this Agreement, Distributor
      shall cease to be an authorized distributor of RTI and:

      A.    All amounts owed by Distributor to RTI shall, without exception,
            become immediately due and payable;

      B.    All unshipped orders may be cancelled without liability of either
            party to the other;

      C.    Neither party shall be liable to the other because of such
            termination for compensation, reimbursement or damages on account of
            the loss of prospective profits or anticipated distributions, or on
            account of expenditures, investments, leases or commitments in
            connection with the business or goodwill of RTI or Distributor or
            for any other reason whatsoever growing out of such termination.

19.   Use of Name Prohibited. On termination of this Agreement, Distributor will
      remove and not thereafter use any sign containing any trade name, logo or
      trademark of RTI including, but not limited to, "Regeneration
      Technologies, Inc.," or "RTI" and will immediately destroy all stationery,
      advertising matter and other printed matter in its possession or under its
      control containing such name, or any of RTI trademarks, trade names or
      logos. Distributor will not at any time after such termination use or
      permit any such trademark, trade name or logo to be used in any manner in
      connection with any business conducted by it or in which it may have an
      interest, or otherwise whatsoever as descriptive of or referring to
      anything other than merchandise or products of RTI. Regardless of the
      cause of termination, Distributor will immediately take all appropriate
      steps to remove and cancel its listings in telephone books, and other
      directories, and public records, or elsewhere that contain the RTI name,
      logo or trademark. If Distributor fails to obtain such removals or
      cancellations promptly, RTI may make application for such removals or
      cancellations on behalf of Distributor and in Distributor's name and in
      such event Distributor will render every assistance.

20.   Acknowledgments. Each party acknowledges that no other representation,
      statement, understanding or agreement, has been made, or exists between
      the parties, except for the Confidential Information Agreement executed
      between the parties on February 2, 1998, and that neither party has relied
      on anything done or said or on any presumption in fact or in law, (1) with
      respect to this Agreement, or to the duration, termination or renewal of
      this Agreement, or with respect to the relationship between the parties,
      other than as expressly set forth in this Agreement; or (2) that in any
      way tends to change or modify the terms, or any of them, of this Agreement
      or to prevent this Agreement becoming effective; or (3) that in any way
      affects or relates to the subject matter hereof. Distributor also
      acknowledges that the terms and conditions of this Agreement, and each of
      them, are reasonable, fair and equitable.

                                        6
<PAGE>

21.   Right of First Negotiation. In the event RTI develops any new technology,
      invention, process, or application within the Field of Use (the "New
      Technology"), RTI grants to Distributor the exclusive right to negotiate
      an agreement for distribution or licensing of the New Technology. Such
      exclusive right shall be limited in duration to ninety (90) days from the
      date RTI advises Distributor of the existence of the New Technology. If
      the parties hereto fail to conclude an agreement with respect to the New
      Technology within ninety (90) days following such notice, RTI will be free
      to negotiate an agreement with any other party concerning the New
      Technology.

22.   Final Agreement. This Agreement may be modified only by a further writing
      that is duly executed by both parties.

23.   Assignment. Neither this Agreement nor any interest in this Agreement may
      be assigned by either party without the prior written approval of the
      other party and such consent shall not be unreasonably withheld.

24.   No Implied Waivers. Except as expressly provided in this Agreement, waiver
      by either party, or failure by either party to claim a default, of any
      provision of this Agreement shall not be a waiver of any default or
      subsequent default.

25.   Notices. Any notice required by this Agreement or given in connection with
      it, shall be in writing and shall be given to the appropriate party by
      personal delivery or by certified mail, postage prepaid, or recognized
      overnight delivery services.

      If to RTI:            Regeneration Technologies, Inc.
                            One Innovation Drive
                            Alachua, Florida 32615
      If to Distributor:    Bard Urological Division, C.R. Bard, Inc.
                            8195 Industrial Boulevard
                            Covington, Georgia 30014
      With copy to:         CR Bard, Inc.
                            730 Central Avenue
                            Murray Hill, NJ 07974
                            Att:  Office of General Counsel

26.   Governing Law and Venue. This Agreement shall be construed and enforced in
      accordance with the laws of the state of Florida. Venue for any legal
      proceeding or action at law arising out of or construing this Agreement
      shall lie in the state courts of Alachua County, Florida, or the United
      States District Court for the Northern District of Florida, Gainesville
      Division.

27.   Severability. If any term of this Agreement is held by a court of
      competent jurisdiction to be invalid or unenforceable, then this
      Agreement, including all of the remaining terms, will remain in full force
      and effect as if such invalid or unenforceable term had never been
      included.

                                        7

<PAGE>

28.   Headings. Headings used in this Agreement are provided for convenience
      only and shall not be used to construe meaning or intent.

29.   Counterparts. This Agreement may be executed in several counterparts, each
      of which shall be deemed an original, and all of which shall constitute
      but one and the same instrument.

30.   License.

      A.    RTI hereby acknowledges that a reliable and continuous source of
            supply of the RTI Product is imperative to Distributor's successful
            distribution efforts. Therefore, as a material inducement to the
            execution of this Agreement by Distributor, RTI hereby grants
            Distributor an exclusive license under RTI's proprietary rights
            limited to the RTI Products, and existing as of the effective date
            herein, to process, have processed, use and distribute an analogue
            of the RTI Product in the Territory and Field Use. Upon request from
            Distributor, RTI shall assist Distributor in locating a suitable
            processor for such licensed analogues. Distributor agrees, however,
            to withhold the exercise of its rights under such license until the
            occurrence of, and only for the duration of, the following:

            (i) RTI's insolvency, or general assignment for the benefit of its
            creditors; a filing for bankruptcy; a filing against it of a
            petition in bankruptcy which is not dismissed before an order for
            relief is entered; a petition filing in any state or federal
            proceeding seeking relief from creditors; but only if any such
            actions set forth in Section 30 (i) herein prevent RTI from meeting
            processing and shipping obligations hereunder; or

            (ii) RTI's breach of any of its duties or responsibilities hereunder
            if such breach is not cured within sixty (60) days of RTI's receipt
            of notice of such breach, or upon RTI's inability to supply the
            quantity of RTI Products set forth in the Distribution Quota
            Schedule if such inability is not cured within ninety (90) days of
            written notice from Distributor.

      B.    In the event Distributor elects to utilize the exclusive license
            granted herein, it shall notify RTI in writing within thirty (30)
            days of Distributor's knowledge of an occurrence as set forth in
            Section 30(A)(i) and (ii) herein. Distributor shall pay Ri] a
            royalty of two percent (2%) of the net distribution fee of any
            product distributed under such license. "Net distribution fee" as
            used in this Section 30(B) shall mean the gross amount indicated on
            invoices for such distributed products less trade and quantity
            discounts; returns; and freight charges. Royalties, if any, shall be
            paid to RTI in U.S. Dollars, with an accounting of how such
            royalties were determined, within forty five (45) days following the
            end of each calendar quarter in which Distributor utilizes such
            license.

                         (SIGNATURES ON NEXT PAGE)

                                         8

<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.

Witnesses                              Regeneration Technologies, Inc.

                                       /s/ James M. Grooms
-------------------------------        -----------------------------------------
                                       By: James M. Grooms
                                       Title: President & CEO

-------------------------------

                                       Bard Urological Division, C.R. Bard, Inc.

                                       /s/ Burt Gersley
-------------------------------        -----------------------------------------
                                       By: Burt Gersley
                                       Title: President

-------------------------------

                                          9
<PAGE>

                              "RETURN INSTRUCTIONS"

1.    Custom processed tissues will not be accepted for return by RTI.

2.    Freeze Dried Tissue will be accepted for return within the first thirty
      days of purchase on the following basis:

      a.    Upon request from customer RTI will fax customer a "Return
            Authorization" form. Such form must be completed by customer and
            included with return shipment.

      b.    Tissue must be in the same condition as when it left RTI.

      c.    Purchaser will pay freight from and back to RTI.

      d.    Purchaser will pay a twenty percent (20%) restocking fee for the
            tissue(s) being returned.

3.    Freeze Dried Tissue will be accepted for return after thirty days on the
      following basis:

      a.    Tissue must be in the same condition as when it left RTI, and must
            have a minimum of twelve (12) months before expiration.

      b.    The purchaser will pay freight from and back to RTI.

      c.    The purchaser will pay a forty percent (40%) restocking fee.

<PAGE>

                            "TRANSFER QUOTA SCHEDULE"

1.    Period I - first eighteen (18) months commencing with the effective date
      of Agreement: [*****]

2.    Period II - twelve (12) months commencing with the end of Period I:
      [*****]

3.    Period III - twelve (12) months commencing with the end of Period II:
      [*****]

4.    Period IV - remainder of Agreement term commencing with the end of Period
      III: [*****]

[CONFIDENTIAL]
<PAGE>

                            Fascia Lata Fee Schedule

Reorder#           Size              Fee
--------           ----              ---

483042             4cm x 2cm         [*****]
483047             7cm x 4cm         [*****]
483212             l2cm x 2cm        [*****]
483412             l2cm x 4cm        [*****]
483812             l2cm x 8cm        [*****]

[CONFIDENTIAL]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}]]